Prophylaxis and treatment of venous thromboembolism in patients with cancer: An update

Internal and Emergency Medicine

Volumn 1, Issue 4, 2006, Pages 273-278

  Falciani, Michela ^a   Imberti, Davide ^b   Prisco, Domenico ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Hospital of Piacenza   (Italy)

Author keywords

Oncology; Prophylaxis; Therapy; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

CENTRAL VENOUS CATHETERIZATION; HUMAN; META ANALYSIS; METHODOLOGY; NEOPLASM; REVIEW; RISK FACTOR; THROMBOEMBOLISM; TIME; VEIN THROMBOSIS;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; META-ANALYSIS; NEOPLASMS; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS; VENOUS THROMBOSIS;

EID: 33846965224     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/BF02934760     Document Type: Article

References (36)

1. P Prandoni A Piccioli A Girolami 1999 Cancer and venous thromboembolism: an overview Haematologica 84 437 45
2. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicenter trial.Lancet 1975; ii: 45-51.
3. WH Geerts GF Pineo JA Heit 2004 Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 338S 400S
4. P Mismetti S Laporte JY Darmon A Buchmuller H Decousus 2001 Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery Br J Surg 88 913 30
5. PG Clagett JS Reisch 1988 Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis Ann Surg 208 227 40
6. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.Br J Surg 1988; 75: 1058-63.
7. ENOXACAN Study Group 1997 Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a doubleblind randomized multicentre trial with venographic assessment Br J Surg 84 1099 103
8. D Bergqvist 2001 Venous thromboembolism and cancer: prevention of VTE Thromb Res 102 V209 V213
9. D Bergqvist G Agnelli AT Cohen for the ENOXACAN II Investigators 2002 Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer N Engl J Med 346 975 80
10. MS Rasmussen P Wille-Jorgensen LN Jorgensen 2005 Extended out-of-hospital low-molecular-weight heparin prophylaxis against venous thromboembolism in patients after cancer operations: a meta-analysis [abstract] J thromb Haemost 3 Suppl 1 P2213 P2213
11. HM Otten J Mathijssen H ten Cate 2004 Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon Arch Intern Med 164 190 4
12. M Levine J Hirsh M Gent 1994 Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer Lancet 343 886 9
13. SK Haas AK Kakkar B Kemkes-Matthes 2005 Prevention of venous thromboembolism with low-molecular-weight heparin in patients with metastatic breast or lung cancer-results of the TOPIC studies [abstract] J Thromb Haemost 3 Suppl 1 OR059 OR059
14. AA Khorana CW Francis E Culakova GH Lyman 2005 Elevated platelet count increases the risk of thromboembolism during outpatient chemotherapy [abstract] J Thromb Haemost 3 Suppl 1 P1598 P1598
15. CJ Van Rooden ME Tesselaar S Osanto FR Rosendaal MV Huisman 2005 Deep vein thrombosis associated with central venous catheters-a review J Thromb Haemost 3 2409 19
16. MM Bern JJ Lokich SR Wallach 1990 Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial Ann Intern Med 112 423 8
17. M Monreal A Alastrue M Rull 1996 Upper extremity deep vein thrombosis in cancer patients with venous access devices-prophylaxis with a low molecular weight heparin (Fragmin) Thromb Haemost 75 251 3
18. S Couban M Goodyear M Burnell 2005 Randomized placebo-controlled study of low-dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer J Clin Oncol 23 4063 9
19. P Reichard A Kretzschmar M Biakhov 2002 A phase III double blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight heparin (dalteparin) in preventing catheter-related complications in cancer patients with central venous catheters [abstract] Proc Am Soc Clin Oncol 21 1474 1474
20. M Verso G Agnelli S Bertoglio FC Di Somma 2005 Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients J Clin Oncol 23 4057 62
21. M Verso G Agnelli PW Kamphuisen for the ETHIC Study 2005 Risk factors for CVC-associated thrombosis in cancer patients: analysis of ETHICS study [abstract] J Thromb Haemost 3 Suppl 1 P2188 P2188
22. MN Levine AY Lee 1999 Treatment of venous thromboembolism in cancer patients Semin Thromb Hemost 25 245 9
23. PA Thodiyil DC Walsh AK Kakkar 2001 Thromboprophylaxis in the cancer patient Acta Haematol 106 73 80
24. KI Pritchard AH Paterson NA Paul B Zee S Fine J Pater 1996 Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group J Clin Oncol 14 2731 7
25. B Fisher JP Costantino DL Wickermham 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371 88
26. IE Smith M Dowsett 2003 Aromatase inhibitors in breast cancer N Engl J Med 348 2431 42
27. MM Samama AT Cohen JY Darmon 1999 A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 793 800
28. R Alikhan AT Cohen S Combe 2004 Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study Arch Intern Med 164 963 8
29. W Ageno R Grimwood S Limbiati F Dentali L Steidl PS Wells 2005 Home-treatment of deep vein thrombosis in patients with cancer Haematologica 90 220 4
30. S Siragusa C Arcara A Malato 2005 Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients Ann Oncol 16 Suppl 4 iv136 iv139
31. P Prandoni AW Lensing A Piccioli 2002 Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 3484 8
32. G Meyer Z Marjanovic J Valcke 2002 Comparison of lowmolecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study Arch Intern Med 162 1729 35
33. AY Lee MN Levine RI Baker for the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators 2003 Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 146 53
34. R Hull GF Pineo AF Mah RF Brant for the LITE Investigators 2003 A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months vs intravenous heparin followed by warfarin sodium in patients with current cancer [abstract] J Thromb Haemost 1 Suppl 1 P1373 P1373
35. AK Kakkar MN Levine Z Kadziola 2004 Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) J Clin Oncol 22 1944 8
36. CP Klerk SM Smorenburg HM Otten 2005 The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2130 5